Treatment of hair loss.
Price
V H
VH
Department of Dermatology, University of California at San Francisco, USA.
D058891:5-alpha Reductase Inhibitors; D000287:Administration, Topical; D000505:Alopecia / Q000188:drug therapy* / Q000503:physiopathology; D000506:Alopecia Areata / Q000188:drug therapy / Q000628:therapy*; D000875:Anthralin / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000075202:Contraindications; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D018120:Finasteride / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006197:Hair / Q000254:growth & development; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008914:Minoxidil / Q000627:therapeutic use
D058891:5-alpha Reductase Inhibitors; D000893:Anti-Inflammatory Agents; D004791:Enzyme Inhibitors; D005938:Glucocorticoids; D018120:Finasteride; D008914:Minoxidil; D000875:Anthralin